Development of foreign body giant cells in response to implantation of Spongostan® as a scaffold for cartilage tissue engineering

In Vivo

Volumn 22, Issue 2, 2008, Pages 203-206

  Cegielski, Marek ^a   Izykowska, Ilona ^a   Podhorska Okolow, Marzena ^a   Zabel, Maciej ^a,b   Dziegiel, Piotr ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cartilage tissue engineering; Foreign body giant cells; Rabbit; Spongostan

Indexed keywords

BIOMATERIAL; SPONGOSTAN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE GRAFT; CONTROLLED STUDY; FEMALE; FOREIGN BODY; GIANT CELL; HISTOPATHOLOGY; INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; RABBIT; TISSUE ENGINEERING;

EID: 42149100043     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kos M, Staniszewska-Kus J, Matusiewicz M, Łuczak K, Klempous R and Pielka S: Tissue reaction after implantation of Spongostan, as the carrier of xenogenic bone morphogenetic protein. Experimental Study. Polim Med 33(1-2): 25-33, 2003.
2. Paganelli C, Fontana P, Porta F, Majorana A, Pazzaglia UE and Sapelli PL: Indication of suitable scaffold as carrier of stem cells in the alveoloplasty of cleft palate. J Oral Rehabil 33: 625-629, 2006.
3. Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ and Bornstein P: The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165(6): 2157-2166, 2004.
4. Kao WJ: Evaluation of protein-modulated macrophage behavior on biomaterials: designing biomimetic materials from cellular engineering. Biomaterials 20: 2213-2221, 1999.
5. Tsai AT, Rice J, Scatena M, Liaw L, Ratner BD and Giachelli CM: The role of osteopontin in foreign body giant cell formation. Biomaterials 26: 5835-5843, 2005.
6. Luttikhuizen DT, Anerongen MJ, Feijter PC, Petersen AM, Harmsen MC and Luyn MJA: The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials 27: 5763-5770, 2006.
7. Yagi M, Miyamoto M, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y and Suda T: DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 3: 345-351, 2005.
8. Zaczyńska E, Pielka S, Staniszewska-Kus J, Czarny A, Zywicka B, Paluch D and Dawidowicz A: Comparative evaluation of TNF-α induction in vitro and in local tissue reaction after implantation of HAP/TCP and HAP. Polim Med 33(1-2): 14-24, 2003.
9. Maluf-Meiken LCV, Silva DRM, Duek EAR and Alberto-Rincon MC: Morphometrical analysis of multinucleated giant cells in subdermal implants of polylactic acid in rats. J Mater Sci: Mater Med 17: 481-485, 2006.
10. Alpaslan C, Alpaslan GH and Oygur T: Tissue reaction to three subcutaneously implanted local hemostatic agents. Br J Oral Maxillofac Surg 35: 129-132, 1997.
11. Riegels-Nielsen P, Grieff J and Løvgreen Nielsen P: Spongostan used for space obliteration in bone defects. Acta Orthop Belg 52(1): 46-53, 1986.